Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes (2024)
Diabetes/Metabolism Research and Reviews
(Refereed journal article or data article (A1))
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events (2024)
JAMA: Journal of the American Medical Association
(Refereed journal article or data article (A1))
Acute exercise mobilizes CD8(+) cytotoxic T cells and NK cells in lymphoma patients (2023)
Frontiers in Physiology
(Refereed journal article or data article (A1))
The KMT2A recombinome of acute leukemias in 2023. (2023)
Leukemia
(Refereed journal article or data article (A1))
Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach (2023)
International Journal of Biological Macromolecules
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes (2024)
Diabetes/Metabolism Research and Reviews
(Refereed journal article or data article (A1))
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events (2024)
JAMA: Journal of the American Medical Association
(Refereed journal article or data article (A1))
Acute exercise mobilizes CD8(+) cytotoxic T cells and NK cells in lymphoma patients (2023)
Frontiers in Physiology
(Refereed journal article or data article (A1))
The KMT2A recombinome of acute leukemias in 2023. (2023)
Leukemia
(Refereed journal article or data article (A1))
Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach (2023)
International Journal of Biological Macromolecules
(Refereed journal article or data article (A1))